---
title: "TONGDA GROUP's subsidiary subscribed to a total of HKD 66 million financial products"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243245523.md"
description: "According to the Zhitong Finance APP, TONGDA GROUP announced that on May 9, 2025, and June 5, 2025, its indirectly non-wholly-owned subsidiary Tongda Smart Tech will use its idle funds to subscribe to several financial products, including subscribing to (i) the first financial product of Xiamen International Bank and the second financial product of Xiamen International Bank, with subscription amounts of RMB 18 million and RMB 48 million, respectively"
datetime: "2025-06-05T09:53:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243245523.md)
  - [en](https://longbridge.com/en/news/243245523.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243245523.md)
generator: "portal-rs"
---

# TONGDA GROUP's subsidiary subscribed to a total of HKD 66 million financial products

According to the Zhitong Finance APP, TONGDA GROUP (00698) announced that on May 9, 2025, and June 5, 2025, its indirectly non-wholly-owned subsidiary Tongda Smart Tech will use its idle funds to subscribe to several financial products, including subscribing to (i) the first financial product of Xiamen International Bank and the second financial product of Xiamen International Bank, with subscription amounts of RMB 18 million and RMB 48 million, respectively

### Related Stocks

- [00698.HK](https://longbridge.com/en/quote/00698.HK.md)
- [001368.CN](https://longbridge.com/en/quote/001368.CN.md)

## Related News & Research

- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Omdia: Foldable smartphone shipments will double to 36 million units by 2028. | TTGT Stock News](https://longbridge.com/en/news/296455533.md)
- [REG - Odyssean Inv. Trust - Issue of Equity](https://longbridge.com/en/news/296372102.md)
- [Aikobio’s AK0406 flu prevention drug wins China IND clearance for clinical trials](https://longbridge.com/en/news/296204995.md)
- [WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence](https://longbridge.com/en/news/296174802.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**